Biomica Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biomica ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biomica Ltd Today - Breaking & Trending Today

Evogene : Q1 2024 Consolidated Financial Statements

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF. ....

United States , Lavie Bio , Yaron Eldad , Foods Ltd , Ceres Global Ag Corp , Israeli Innovation Authority , Agplenus Ltd , Lavie Bio Ltd , Commission File Number , Strauss Group , More International , Evogene Ltd , Casterra Ag Ltd , Exchange Commission , Biomica Ltd , Securities Exchange , File Number , Feinstein Street , Park Rehovot , Foreign Private Issuer , Securities Exchange Act , Evogene Reports First Quarter , Finally Foods , Kitchen Foodtech Hub , Finally Foods Ltd , Israeli Innovation ,

Evogene Reports First Quarter 2024 Financial Results

Conference call and webcast: today, May 23, 2024, 9:00 am ET Financial and Business Highlights: Q1 2024 revenue: $4.2M vs. $0.6M in Q1 2023; anticipating. ....

United States , Lavie Bio , Ofer Haviv , Rachel Pomerantz Gerber , Strauss Group , Foods Ltd , Ceres Global Ag Corp , Evogene Ltd , Casterra Ag Ltd , Biomica Ltd , Israeli Innovation Authority , Prnewswire Evogene Ltd , Agplenus Ltd , Business Highlights , Finally Foods , Kitchen Foodtech Hub , Finally Foods Ltd , Israeli Innovation , Verb Biotics , Verb Biotic , Digestive Disease Week , Marketing Expenses , Administrative Expenses , Webcast Details , Investorsrelations Contact , Pomerantz Gerber ,

Evogene Reports First Quarter 2024 Financial Results - Evogene

Conference call and webcast: today, May 23, 2024, 9:00 am ET
Financial and Business Highlights:
Q1 2024 revenue: $4.2M vs. $0.6M in Q1 2023; anticipating continued growth in 2024.
Q1 2024 net loss:. ....

United States , Rachel Pomerantz Gerber , Lavie Bio , Ofer Haviv , Agplenus Ltd , Ceres Global Ag Corp , Biomica Ltd , Israeli Innovation Authority , Foods Ltd , Evogene Ltd , Lavie Bio Ltd , Strauss Group , Casterra Ag Ltd , More International , Business Highlights , Kitchen Foodtech Hub , Verb Biotics , Verb Biotic , Digestive Disease Week , Marketing Expenses , Administrative Expenses , Webcast Details , Investors Relations Contact , Pomerantz Gerber , Investor Relations ,

Evogene : Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF. ....

United States , Elran Haber , Rachel Pomerantz Gerber , Lavie Bio , Gal Markel , Yaron Eldad , Commission File Number , American Society Of Clinical Oncology Inc , Exchange Commission , Evogene Ltd , Rabin Medical Center , Association For Clinical Oncology , Davidoff Cancer Center , Biomica Ltd , Securities Exchange , American Society Of Clinical Oncology , File Number , Feinstein Street , Park Rehovot , Foreign Private Issuer , Presents Positive Clinical Data Update , Ongoing Phase , Microbiome Based Therapeutic , Securities Exchange Act , Clinical Oncology , Scientific Advisory Board ,

Biomica Reveals Positive Data From Phase 1 Trial Of BMC128 In Cancer Treatment; Stock Up

Biomica Ltd., a subsidiary of Evogene Ltd. (EVGN), Thursday announced positive data from its ongoing Phase 1 trial of microbiome-based immuno-oncology candidate, BMC128, in combination with nivolumab, for the treatment of patients with non-small cell lung cancer or NSCLC, melanoma, or renal cell carcinoma or RCC. ....

Evogene Ltd , Biomica Ltd ,